Prevention and reduction of blood loss

Details Prevention and reduction of blood loss Prevention and reduction of blood loss

2007-10-31

2010-12-14

Kam, Chih-Min (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C530S324000

Reexamination Certificate

active

07851442

ABSTRACT:
Kits containing a dry lyophilized kallikrein inhibitor are described.

REFERENCES:
patent: 3691016 (1972-09-01), Patel
patent: 3969287 (1976-07-01), Jaworek et al.
patent: 4118481 (1978-10-01), Schnabel et al.
patent: 4153687 (1979-05-01), Schnabel et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4195128 (1980-03-01), Hildebrand et al.
patent: 4229537 (1980-10-01), Hodgins et al.
patent: 4247642 (1981-01-01), Hirohara et al.
patent: 4330440 (1982-05-01), Ayers et al.
patent: 4609725 (1986-09-01), Brady et al.
patent: 4931385 (1990-06-01), Block et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5372933 (1994-12-01), Zamarron
patent: 5441931 (1995-08-01), Sprecher et al.
patent: 5444156 (1995-08-01), Veloso et al.
patent: 5576294 (1996-11-01), Norris et al.
patent: 5635187 (1997-06-01), Bathurst et al.
patent: 5677146 (1997-10-01), Sprecher et al.
patent: 5719041 (1998-02-01), Lazarus et al.
patent: 5747449 (1998-05-01), Lasters et al.
patent: 5770568 (1998-06-01), Auerswald et al.
patent: 5780265 (1998-07-01), Dennis et al.
patent: 5786328 (1998-07-01), Dennis et al.
patent: 5795865 (1998-08-01), Markland et al.
patent: 5795954 (1998-08-01), Lazarus et al.
patent: 5800385 (1998-09-01), Demopulos et al.
patent: 5834244 (1998-11-01), Dennis et al.
patent: 5843895 (1998-12-01), Lazarus et al.
patent: 5863893 (1999-01-01), Dennis et al.
patent: 5874407 (1999-02-01), Kelley et al.
patent: 5880256 (1999-03-01), Dennis et al.
patent: 5962266 (1999-10-01), White et al.
patent: 5994125 (1999-11-01), Markland et al.
patent: 6004579 (1999-12-01), Bathurst et al.
patent: 6010880 (2000-01-01), Markland et al.
patent: 6013763 (2000-01-01), Braisted et al.
patent: 6057287 (2000-05-01), Markland et al.
patent: 6071723 (2000-06-01), Markland et al.
patent: 6087473 (2000-07-01), Conklin et al.
patent: 6090916 (2000-07-01), Vlasuk et al.
patent: 6103499 (2000-08-01), Markland et al.
patent: 6113896 (2000-09-01), Lazarus et al.
patent: 6159938 (2000-12-01), Gyorkos et al.
patent: 6180607 (2001-01-01), Davies et al.
patent: 6261279 (2001-07-01), Demopulos et al.
patent: 6306884 (2001-10-01), Buckman et al.
patent: 6333402 (2001-12-01), Markland et al.
patent: 6423498 (2002-07-01), Markland et al.
patent: 7064107 (2006-06-01), Ladner et al.
patent: 7153829 (2006-12-01), Ladner et al.
patent: 7166576 (2007-01-01), Cicardi et al.
patent: 7235530 (2007-06-01), Blair et al.
patent: 7276480 (2007-10-01), Ladner et al.
patent: 2001/0027180 (2001-10-01), Isaacs
patent: 2004/0038893 (2004-02-01), Ladner et al.
patent: 2004/0053206 (2004-03-01), Cicardi et al.
patent: 2004/0171794 (2004-09-01), Ladner et al.
patent: 2005/0164928 (2005-07-01), Ladner et al.
patent: 2006/0069020 (2006-03-01), Blair et al.
patent: 2007/0049522 (2007-03-01), Ladner et al.
patent: 2007/0213275 (2007-09-01), Clark et al.
patent: 2007/0249807 (2007-10-01), Ladner et al.
patent: 2008/0064637 (2008-03-01), Ladner et al.
patent: 2008/0076712 (2008-03-01), Ladner et al.
patent: 2008/0131426 (2008-06-01), Ladner et al.
patent: 2008/0139473 (2008-06-01), Ladner et al.
patent: 2008/0152656 (2008-06-01), Ladner et al.
patent: 2008/0188409 (2008-08-01), Blair et al.
patent: 2008/0221031 (2008-09-01), Blair et al.
patent: 2008/0226655 (2008-09-01), Ladner et al.
patent: 2008/0260752 (2008-10-01), Ladner et al.
patent: 2009/0082267 (2009-03-01), Ladner et al.
patent: E 275583 (2005-04-01), None
patent: 2 180 950 (2005-03-01), None
patent: 695 33 472 (2006-01-01), None
patent: 0 285 123 (1988-10-01), None
patent: 0 621 870 (1997-05-01), None
patent: 0 621 871 (1997-07-01), None
patent: 739 355 (2004-09-01), None
patent: 1 484 339 (2004-12-01), None
patent: WO8910374 (1989-11-01), None
patent: WO9206111 (1992-04-01), None
patent: WO9309233 (1993-05-01), None
patent: WO 93/14120 (1993-07-01), None
patent: WO 93/14121 (1993-07-01), None
patent: WO 93/14122 (1993-07-01), None
patent: WO9518830 (1995-07-01), None
patent: WO 95/21601 (1995-08-01), None
patent: WO99/63090 (1999-12-01), None
patent: WO0179480 (2001-10-01), None
patent: WO030667824 (2003-08-01), None
patent: WO 03/103475 (2003-12-01), None
patent: WO 2004/019968 (2004-03-01), None
PCT International Search Report dated Jul. 21, 2008 and issued in PCT/US05/34335.
PCT Written Opinion dated Jul. 21, 2008 and issued in PCT/US05/34335.
Attwood, The Babel of Bioinformatics; Science, vol. 290, pp. 471-473 (2000).
Skolnick and Fetrow, From Genes to Protein Structure and Function: Novel Applications of Computational Approaches in the Genomic Era; Trends in Biotechnology, vol. 18, pp. 34-39 (2000).
Wendel et al., Lower Cardiac Troponin T Levels in Patients Undergoing Cardiopulmonary Bypass and Receiving High-Dose Aprotinin Therapy Indicate Reduction of Perioperative Myocardial Damage; Journal of Thoracic Cardiovascular Surgery, vol. 109, No. 6, pp. 1164-1172 (1995).
Adelman et al., “Proteolysis of Platelet Glycoprotein Ib by Plasmin Is Facilitated by Plasmin Lysine-Binding Regions,”Blood, 68:1280-1284 (1986).
Albrecht et al., “Elastase Inhibition by the Inter-α-Trypsin Inhibitor and Derived Inhibitors of Man and Cattle,”Hoppe-Seyler's Z. Physiol. Chem., 364:1697-1702 (1983).
Albrecht et al., “Kunitz-Type Proteinase Inhibitors Derived by Limited Proteolysis of the Inter-α-Trypsin Inhibitor, IX[1-8],”Hoppe-Seyler's Z. Physiol. Chem., 364:1703-1708 (1983).
Anba et al., “Improving the stability of a foreign protein in the periplasmic space ofEscherichia coli,” Biochimie, 70:727-733 (1988).
Angliker et al., “The synthesis of lysylfluoromethanes and their properties as inhibitors of trypsin, plasmin and cathepsin B,”Biochem. J., 241:871-875 (1987).
Atherton et al., “Peptide synthesis. Part 2. Procedures for Solid -phase Synthesis using Nα-Fluorenylmethoxycarbonylamino-acids on Polyamide Supports. Synthesis of Substance P and of Acyl Carrier Protein 65-74 Decapeptide,”J. Chem. Soc. Perkin Trans., 1:538-546 (1981).
Auerswald et al., “Expression, Isolation and Characterization of Recombinant [Arg15,Glu52] Aprotinin,”Bio. Chem. Hoppe-Seyler, 369:(Suppl)27-35 (1988).
Balduyck et al., “Human Urinary Proteinase Inhibitor: Inhibitory Properties and Interaction with Bovine Trypsin,”Bio. Chem. Hoppe-Seyler, 366:9-14 (1985).
Baneyx and Georgiou, “In Vivo Degradation of Secreted Fusion Proteins by theEscherichia coliOuter Membrane Protease OmpT”J. Bacteriol., 172:491-494 (1990).
Baneyx and Georgiou, “Construction and Characterization ofEscherichia coliStrains Deficient in Multiple Secreted Proteases: Protease III Degrades High-Molecular-Weight Substrates In Vivo,”J. Bacteriol., 173:2696-2703 (1991).
Berndt et al., “Designed Replacement of an Internal Hydration Water Molecule in BPTI: Structural and Functional Implications of a Glycine-to-Serine Mutation,”Biochem., 32:4564-4570 (1993).
Bhoola et al., “Bioregulation of Kinins: Kallikreins, Kininogens, and Kininases,”Pharmacological Reviews, 44:1-80 (1992).
Browne et al., “Expression of Recombinant Human Plasminogen and Aglycoplasminogen in HeLa Cells,”GeneBank, Accession No. M74220 (1991).
Broze et al., “Regulation of Coagulation by a Multivalent Kunitz-Type Inhibitor,”Biochem., 29:7539-7546 (1990).
Brus et al., “Disease Severity is Correlated With Plasma Clotting and Fibrinolytic and Kinin-Kallikrein Activity in Neonatal Respiratory Distress Syndrome,”Pediatr. Res., 41:120-127 (1997).
Budavari, ed., Merck Index, 11thEdition, ISBN 911910-28-X, entries 923, 1745, 2740, 7425 (1989).
Chung et al., “Human Plasma Prekallikrein, a Zymogen to a Serine Protease That Contains Four Tandem Repeats,”GenBank, Accession No. P03952 (1995).
Colman et al., “Activation of the Kallikrein-Kinin System in Arthritis and Enterocolitis in Genetically Susceptible Rats: Modulation by a Selective Plasma Kallikrein Inhibitor,”Proc. Assoc. Am. Physicians, 109:10-22 (1997).
Cumming and Nimmo, “Hemodynamic, Renal, and Ho

Affiliated with

Also associated with

Rating

Prevention and reduction of blood loss does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention and reduction of blood loss, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and reduction of blood loss will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4182705